Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Adjuvant Chemotherapy With Gemcitabine Plus S-1 in Patients With Biliary Tract Cancer Undergoing Curative Resection Without Major Hepatectomy

NCT01713387 is registered in ClinicalTrials.gov with Kansai Hepatobiliary Oncology Group as lead sponsor.

NCT NCT01713387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01713387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Adjuvant Chemotherapy With Gemcitabine Plus S-1 in Patients With Biliary Tract Cancer Undergoing Curative Resection Without Major Hepatectomy
Lead sponsor
Kansai Hepatobiliary Oncology Group
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2012
Completion date
March 31, 2017
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer